Company logo

HQY - HealthEquity, Inc.

NASDAQ -> Healthcare -> Health Information Services
Draper, United States
Type: Equity
HQY price evolution
HQY
(in millions $) 1 May 2025 31 Jan 2025 31 Aug 2024 30 Jul 2024
Current assets
Cash $326.89
Short term investments
Net receivables $106.71 $108.45 $106.22
Inventory
Total current assets $495.25 $495.63 $404.9
Long term investments
Property, plant & equipment $48.73 $51.08 $53.19
Goodwill & intangible assets $2902.36
Total noncurrent assets $3018.84
Total investments
Total assets $3488.35 $3514.47 $3246.48
Current liabilities
Accounts payable $10.35 $10.56 $18.17
Deferred revenue
Short long term debt $9.89
Total current liabilities $154.54 $120.91 $92.22
Long term debt $1081.04 $1101.4 $925.67
Total noncurrent liabilities $1236.52
Total debt $1157.45
Total liabilities $1363.66 $1357.43 $1148.7
Shareholders' equity
Retained earnings $231.59 $270.26 $234.44
Other shareholder equity
Total shareholder equity $2157.04
(in millions $) 31 Jan 2025 31 Dec 2023 3 Mar 2023 31 Dec 2021
Current assets
Cash $403.98 $254.27 $225.41
Short term investments
Net receivables $104.89 $96.83 $87.43
Inventory
Total current assets $557.44 $382.89 $351.34
Long term investments
Property, plant & equipment $54.39 $69.32 $86.98
Goodwill & intangible assets $2484.09 $2584.5 $2618.97
Total noncurrent assets $2606.35 $2706.01 $2755.76
Total investments
Total assets $3163.79 $3088.9 $3107.1
Current liabilities
Accounts payable $12.04 $13.9 $27.54
Deferred revenue
Short long term debt $9.4 $27.66 $20.92
Total current liabilities $117.09 $131.06 $153.19
Long term debt $923.74 $907.84 $987.31
Total noncurrent liabilities $1011.68 $1062.2 $1101.34
Total debt $933.14 $994.49 $1008.23
Total liabilities $1128.77 $1193.26 $1254.53
Shareholders' equity
Retained earnings $205.63 $149.92 $176.06
Other shareholder equity
Total shareholder equity $2035.02 $1895.64 $1852.58
(in millions $) 30 Oct 2025 1 May 2025 31 Jan 2025 31 Aug 2024
Revenue
Total revenue $299.93
Cost of revenue
Gross Profit $204.05
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $143.35
Operating income
Income from continuing operations
EBIT
Income tax expense $10.79
Interest expense -$12.32
Net income
Net income $35.82
Income (for common shares)
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $999.59 $861.75 $756.56 $733.57
Cost of revenue $376.95 $371.66 $332.85 $318.24
Gross Profit $622.64 $490.09 $423.71 $415.33
Operating activities
Research & development $218.81 $193.38 $157.36 $124.81
Selling, general & administrative $182.93 $164.48 $142.98 $134.46
Total operating expenses $504.94 $481.03 $447.94 $381.32
Operating income $117.7 $9.06 -$24.24 $34.01
Income from continuing operations
EBIT $130.5 $10.33 -$30.17 $39.02
Income tax expense $19.33 -$11.95 -$22.45 -$4.69
Interest expense $55.45 $48.42 $36.57 $34.88
Net income
Net income $55.71 -$26.14 -$44.29 $8.83
Income (for common shares) $55.71 -$26.14 -$44.29 $8.83
(in millions $) 1 Dec 2024 31 Aug 2024 30 May 2024 2 Mar 2024
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$491.9 -$479.03 -$269.95 -$46.07
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $145.97 $228.39 $51.77 -$47.04
Effect of exchange rate
Change in cash and equivalents -$81.82 -$77.09 -$152.75 $149.71
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $55.71 -$26.14 -$44.29 $8.83
Operating activities
Depreciation $153.08 $161.2 $137.19 $115.9
Business acquisitions & disposals -$3.26 -$70.58 -$504.53
Stock-based compensation $77.15 $62.61 $52.75 $42.86
Total cash flows from operations $242.83 $150.65 $141 $181.62
Investing activities
Capital expenditures -$42.82 -$48.54 -$71.62 -$64.59
Investments $2.37
Total cash flows from investing -$46.07 -$119.13 -$639.25 -$96.96
Financing activities
Dividends paid
Sale and purchase of stock $6.47 $6.68 $466.39 $295.35
Net borrowings -$54.38 -$8.75 -$65.05 -$239.06
Total cash flows from financing -$47.04 -$2.67 $394.86 $52.42
Effect of exchange rate
Change in cash and equivalents $149.71 $28.85 -$103.39 $137.08
News
HealthEquity, Inc. (HQY): Among the Health Information Services Stocks Outpacing...
Insider Monkey · via Yahoo Finance 15 Feb 2025
Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now
Zacks · via Yahoo Finance 10 Jan 2025
HealthEquity, Inc.'s (NASDAQ:HQY) Stock Has Seen Strong Momentum: Does That Call...
Simply Wall St. · via Yahoo Finance 8 Jan 2025
3 US Stocks That Analysts Estimate Are Trading Below Intrinsic Value
Simply Wall St. · via Yahoo Finance 2 Jan 2025
3 US Stocks That May Be Undervalued By Up To 48.9%
Simply Wall St. · via Yahoo Finance 2 Jan 2025
Brokers Offer Predictions for HealthEquity FY2025 Earnings
ETF DAILY NEWS 1 Jan 2025
Top US Value Stock Picks For January 2025
Simply Wall St. · via Yahoo Finance 1 Jan 2025
3 Undervalued US Stocks Estimated To Be Up To 30.8% Below Intrinsic Value
Simply Wall St. · via Yahoo Finance 1 Jan 2025
3 US Stocks Estimated To Be Trading At Up To 48.2% Below Intrinsic Value
Simply Wall St. · via Yahoo Finance 30 Dec 2024
Sanctuary Advisors LLC Makes New $260,000 Investment in HealthEquity, Inc....
ETF DAILY NEWS 28 Dec 2024
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A

Copyright Statfolio @ 2025

Social Accounts